Two Treatment Modalities for Myogenous Temporomandibular Disorders

ConditionTMD
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorAlexandria University

About this trial

Temporomandibular disorder (TMD) is a common condition with multifactorial etiology, including trauma, emotional stress, parafunctional habits, and occlusal discrepancies. TMD may be classified as myogenous, involving the masticatory and cervical muscles, or arthrogenous, affecting the temporomandibular joint structures. Management approaches range from noninvasive to invasive methods. The intraoral stabilization appliance (SA) is a widely used noninvasive treatment, while the ear stent (ES) has recently been introduced for managing myogenous TMD.

Aim: This randomized clinical trial aims to compare the effectiveness of SA and ES in the management of myogenous TMD.

Eligibility criteria

Qualifiers

Participants presenting with pain score grading at least 4 out of 10 on NRS.

Participants with fully dentate type I occlusion.

Patients experiencing no neurological disorders.

Disqualifiers

Patients with arthrogenous TMJ will be excluded by Magnetic Resonance Imagining (MRI)

Patients who have clicking or crepitation.

Previous history of TMD treatment.

History of recent trauma.

Trial design

Treatments tested in this trial

  • Stabilization Appliance
  • Ear Stent

Treatment groups

32 Participants
are divided into 2 treatment groups

Sponsors and collaborators